Oligoclonal band on the 5-year prognosis of patients with multiple sclerosis.
While the presence of OCBs in patients with MS does not demonstrate a significant prognostic impact over a five-year follow-up period, it could potentially influence the rate of recurrence.
Authors
- Mohammad Amin Habibi (ORCID: https://orcid.org/0000-0001-7600-6925)
- Sajjad Daneshyar (ORCID: https://orcid.org/0000-0002-7553-3843)
- Mojtaba Khazaei (ORCID: https://orcid.org/0000-0002-2360-9260)
- Masoud Ghiasian (ORCID: https://orcid.org/0000-0002-9632-8558)
- Elham Khanlarzadeh (ORCID: https://orcid.org/0000-0003-3265-4570)
Institutions
- Hamedan University of Medical Sciences (IR)
Publication Details
- Journal
- PubMed
- Published
- 2025-01-01
- DOI
- https://doi.org/10.22088/cjim.16.2.284
- Primary Topic
- Systemic Sclerosis and Related Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00